Therapy of diabetic retinopathy with somatotatin analogues;Therapie der diabetischen retinopathie mit somatostatinanaloga

Ophthalmologe

Volumn 101, Issue 3, 2004, Pages 290-293

  Lang, G E ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Diabetic retinopathy; Growth hormon; Insulin like growth factor; Octreotide; Somatostatin analogue

Indexed keywords

ADVANCED GLYCATION END PRODUCT; BASIC FIBROBLAST GROWTH FACTOR; DIACYLGLYCEROL; GONADORELIN; GROWTH HORMONE; OCTREOTIDE; PIGMENT EPITHELIUM DERIVED FACTOR; PLATELET DERIVED GROWTH FACTOR; PROTEIN KINASE C BETA; PROTEIN TYROSINE PHOSPHATASE SHP 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

ANGIOGENESIS; DIABETES MELLITUS; DIABETIC RETINOPATHY; DRUG MECHANISM; HUMAN; HYPERGLYCEMIA; PATHOGENESIS; REVIEW;

CONTROLLED CLINICAL TRIALS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; GROWTH HORMONE; HUMANS; INJECTIONS, INTRAMUSCULAR; INSULIN-LIKE GROWTH FACTOR I; OCTREOTIDE; SOMATOSTATIN; TIME FACTORS;

EID: 1642385108     PISSN: 0941293X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00347-003-0903-2     Document Type: Review

References (18)

1. Böhm BO, Lang GK, Jehle PM, Feldmann B, Lang GE (2001) Octreotide reduces vitreous hemorrhage and loss of visual acuity risk in patients with high-risk proliferative diabetic retinopathy. Horm Metab Res 33:300-306
2. Böhm BO, Lang GE, Volpert O et al (2003) Low content of the natural ocular anti-angiogenic agent pigment epithelium-derived factor (PEDF) in aqueous humor predicts progression of diabetic retinopathy. Diabetologia 46:394-400
3. Brazeau P, Vale W, Burgus R, Ling N, Butcher M, Rivier J et al (1973) Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 179:77-79
4. Danis RP, Bingaman DP (1997) Insulin-like growth factor-1 retinal microangiopathy in the pig eye. Ophthalmology 104:1661-1669
5. Davis MI, Wilson SH, Grant MB (2001) The therapeutic problem of proliferative diabetic retinopathy: Targeting somatostatin receptors. Horm Metab Res 33:295-299
6. Grant MB, Mames RN, Fitzgerald C, Hahariwala KM, Cooper-DeHoff R, Caballero S, Estes KS (2000) The efficacy of octreotide in the therapy of severe nonproliferative and early proliferative diabetic retinopathy. Diabetes Care 23:504-509
7. Grant MB, Caballero S, Smith LEH (2002) Somatostatin in diabetic eye diseases. In: The expanding role of octreotide II: Advances in Endocrinology and eye diseases. Eds Lamberts SWJ, Ghigo E, DioScientifica Ltd, Bristol. 165-184
8. Joussen AM, Fauser S, Krohne TU, Lemmen KD, Lang GE, Kirchhof B (2003) Diabetische Retinopathie: Pathophysiologie und Therapie einer hypoxieinduzierten Entzündung. Ophthalmologe 100:363-370
9. Lang GE, Kampmeier J (2002) Die Bedeutung der Proteinkinase C in der Pathophysiologie der diabetischen Retinopathie. Klin Monatsbl Augenheilkd 219:769-776
10. Patel YC, Greenwood MT, Panetta R, Demchyshyn L, Niznik H, Srikant CB (1995) The somatostatin receptor family. Life Sci 57:1249-1265
11. Poulsen JE (1953) The Houssay phenomenon in man: recovery from retinopathy in a case of diabetes with Simmond,s disease. Diabetes 2:7-12
12. Poulsen JE (1966) Diabetes and anterior pituitary insufficiency: final course and postpartum study of a diabetic patient with Sheehan's syndrome. Diabetes 1S:73-77
13. Spranger J, Mohlig M, Osterhoff M, Bühnen J, Blum WF, Pfeiffer AFH (2001) Retinal photocoagulation does not influence intraocular levels of IGF-I, IGF-II and IGF-BP3 in proliferative diabetic retinopathy - evidence for combined treatment of PDR with somatostatin analogues and retinal photocoagulation? Horm Met Res 33:312-316
14. Spraul CW, Baldysiak-Figiel A, Lang GK, Lang GE (2002) Octreotide inhibits growth factor-induced bovine choriocapillary endothelial cells in vitro. Graefes Arch Clin Exp Ophthalmol 240:227-231
15. Van Hagen PM, Baarsma GS, Mooy CM, Ercoskan EM, Averst E, Hofland LJ, Lamberts SWJ, Kuijpers RWAM (2000) Somatostatin and somatostatin receptors in retinal diseases. Eur J Endocrinol 143:43-51
16. Van Hagen PM, Kuijpers RWAM, Baarsma GS (2002) Somatostatin and somatostatin receptors in the retina. In: The expanding role of octreotide II: Advances in Endocrinology and eye diseases. Eds Lamberts SWJ, Ghigo E, DioScientifica Ltd, Bristol. 143-147
17. Van Hagen PM, Kuijpers RWAM, ter Averst E, Hofland LJ, Baarsma GS (2002) The clinical application of somatostatin analogues in retinal diseases. In: The expanding role of octreotide II: Advances in Endocrinology and eye diseases. Eds Lamberts SWJ, Ghigo E, DioScientifica Ltd, Bristol. 143-147
18. Wachtmeister L (1983) The action of peptides on the Mudpuppy electrogram. Experimental Eye Research 33:429-437